Overview
Intellectual disability (ID), termed Disorders of Intellectual Development in ICD-11, is a neurodevelopmental condition characterised by significant impairments in both intellectual functioning and adaptive behaviour, with onset during the developmental period. The DSM-5 (and DSM-5-TR) uses the term Intellectual Disability (Intellectual Developmental Disorder); ICD-11 replaces the former ICD-10 category of "mental retardation."
People with ID carry a substantially elevated burden of psychiatric illness: the lifetime prevalence of severe psychiatric disorder is estimated at approximately five times that of the general population. Despite this, mental health conditions remain chronically under-recognised, largely due to diagnostic overshadowing, the tendency to attribute behavioural and emotional symptoms to the ID itself rather than recognising them as expressions of comorbid psychiatric disorder. Accurate assessment requires understanding of how ID severity modifies clinical presentation, use of validated adapted tools, and a genuinely multidisciplinary approach.
Epidemiology
| Parameter | Estimate |
|---|---|
| Population prevalence of ID | ~1-3% (varies by definitional criteria) |
| Mild ID (proportion of all ID) | ~85% |
| Moderate ID | ~10% |
| Severe ID | ~4% |
| Profound ID | ~2% |
| Lifetime prevalence of any mental disorder in ID | ~30-50% (vs ~20% general population) |
| Lifetime prevalence of severe psychiatric disorder in ID | ~5× general population rate |
| Co-occurring ASD | ~30-40% of people with ID |
| Co-occurring ADHD | ~20-30% |
| Epilepsy in ID (overall) | ~20-30%; >50% in severe/profound ID |
Australian-specific considerations:
- Rates of ID and co-occurring mental illness are disproportionately elevated in Aboriginal and Torres Strait Islander communities, compounded by fetal alcohol spectrum disorder (FASD), acquired brain injury, poor access to services, transgenerational trauma, and social determinants of health.
- Approximately 40% of Aboriginal people in Cape York presenting with a psychotic disorder were also found to have ID or significant cognitive impairment; clinical distinction between ID and acquired cognitive impairment (e.g. from brain injury, dementia) is essential in this context.
- Co-occurring substance misuse (alcohol, cannabis) further complicates psychiatric comorbidity assessment in some Aboriginal communities.
Aetiology and Psychiatric Phenotypes
Aetiological factors are directly relevant to psychiatric risk stratification because specific syndromes carry characteristic psychiatric phenotypes:
| Syndrome / Aetiology | Associated Psychiatric/Medical Risk |
|---|---|
| Down syndrome (trisomy 21) | Alzheimer-type dementia (often onset 40s-50s); depression; hypothyroidism-related psychiatric features |
| Velocardiofacial syndrome (22q11.2 deletion) | Schizophrenia-spectrum psychosis; anxiety; mood disorders |
| Fragile X syndrome | Anxiety; social phobia; ASD features; mood dysregulation |
| Prader-Willi syndrome | Obsessive-compulsive behaviours; psychosis (especially maternal uniparental disomy subtype); hyperphagia |
| Angelman syndrome | Happy affect; hyperactivity; seizures |
| Fetal alcohol spectrum disorder | ADHD; impulsivity; executive dysfunction; conduct problems |
| Lesch-Nyhan syndrome | Severe self-injurious behaviour (SIB; degree of ID does not predict SIB severity) |
Organic contributors to psychiatric vulnerability:
- Brain damage/dysgenesis → impaired impulse control, frustration tolerance, emotional regulation
- Epilepsy and peri-ictal mood/psychotic phenomena
- Sensory impairments (hearing and vision), particularly prevalent in Aboriginal and Torres Strait Islander peoples; amplifies communicative difficulties and psychosocial stress
- Endocrine comorbidities (e.g. hypothyroidism in Down syndrome)
- Comorbid ASD and ADHD independently associated with high rates of mood disorder
Psychosocial contributors:
- Poverty, unemployment, limited social supports
- Adverse childhood experiences, peer rejection, institutionalisation, abuse, and exploitation
- Awareness of one's own limitations → grief, self-concept problems, depressive reactions
- Individuals with ID tend to have greater sensitivity to interpersonal stressors and fewer coping skills, magnifying the impact of psychosocial adversity
DSM-5-TR and ICD-11 Diagnostic Criteria
DSM-5-TR: Intellectual Disability (Intellectual Developmental Disorder)
| Criterion | Description |
|---|---|
| A | Deficits in intellectual functions (reasoning, problem-solving, planning, abstract thinking, judgement, academic learning, learning from experience), confirmed by both clinical assessment and standardised intelligence testing |
| B | Deficits in adaptive functioning in ≥1 domain (conceptual, social, practical) resulting in failure to meet developmental/sociocultural standards for personal independence and social responsibility |
| C | Onset during the developmental period |
Key DSM-5 changes from DSM-IV:
- Replaces the term "mental retardation" with "intellectual disability"
- Severity levels determined by adaptive functioning (not IQ score alone) across three domains
- Removes the multiaxial system; now uses non-axial documentation combining former Axes I-III, with separate notations for psychosocial/contextual factors (former Axis IV) and disability/global functioning (former Axis V)
- IQ is no longer sufficient alone; adaptive functioning impairment is required and determines severity
Severity classification by adaptive functioning:
| Severity | Conceptual Domain | Social Domain | Practical Domain |
|---|---|---|---|
| Mild | Difficulties with academic skills, abstract thinking; concrete problem-solving | Immature social communication; risk of manipulation | May live independently with guidance; needs support for complex decisions |
| Moderate | Significant lag in academic skills; limited concepts of time/money | Markedly different spoken language; limited social judgement | Needs support with daily activities; works in supervised settings |
| Severe | Limited conceptual skills; numbers/letters mostly not understood | Simple speech limited to present; understands simple communication | Needs assistance with all ADLs |
| Profound | Mostly physical world; fully dependent | Very limited symbolic communication | Fully dependent; may use augmentative communication |
ICD-11: Disorders of Intellectual Development
ICD-11 uses the term Disorders of Intellectual Development with specifiers for mild, moderate, severe, and profound levels. As in DSM-5, requires deficits in both intellectual functioning and adaptive behaviour with onset in the developmental period. The ICD-11 term replaces the ICD-10 category "mental retardation."
Note: DSM-5 also recognises Major and Minor Neurocognitive Disorders due to a range of causes, relevant when acquired cognitive decline superimposes on or mimics ID, particularly in older adults with Down syndrome or in populations with high rates of acquired brain injury.
Assessment
General Principles
- Multi-informant approach: person with ID, carer(s), family members, support workers, teachers
- Multiple sessions across familiar settings, not single-occasion clinic assessment
- Changes in baseline behaviour are the primary diagnostic signal: sleep, appetite, mood, sociability, self-help skills
- Comprehensive framework: intellectual/adaptive functioning → physical health → psychiatric disorder → comorbid neurodevelopmental conditions → psychosocial context (bereavement, trauma, environmental change)
The Problem of Diagnostic Overshadowing
Diagnostic overshadowing is the attribution of signs of mental disorder, agitation, self-injurious behaviour, social withdrawal, sleep disturbance, to the ID itself or to "behavioural problems," thereby missing treatable psychiatric conditions.
Strategies to counteract diagnostic overshadowing:
| Strategy | Rationale |
|---|---|
| Seek change from baseline (informant report) | Mental disorder represents a departure from the individual's usual functioning, not comparison with neurotypical norms |
| Recognise behavioural disturbance as a final common pathway | Aggression, SIB, withdrawal may represent depression, psychosis, pain, abuse, environmental stress, or medication effects |
| Use ID-adapted psychiatric instruments | Standard tools are not validated for moderate-profound ID |
| Screen systematically for physical causes | Pain, constipation, GORD, UTI, dental disease, medication toxicity can all present as behavioural change |
| Obtain longitudinal developmental history | Distinguishes episodic psychiatric change from stable behavioural phenotype |
Relevance of ID Severity to Assessment
| ID Severity | Key Assessment Implications |
|---|---|
| Mild | Verbal self-report possible; standard psychiatric criteria more applicable with adaptation; higher risk of unrecognised psychiatric disorder due to superficially adequate presentation |
| Moderate | Partial verbal report; relies heavily on informant; behavioural indicators essential; simplified language and visual aids required |
| Severe | Minimal verbal communication; almost entirely behavioural and physiological indicators; pain and discomfort may drive all presentations |
| Profound | Non-verbal; fully dependent on observational assessment by familiar carers; changes in physiological state (eating, sleep, motor behaviour) are primary data |
Intellectual and Adaptive Functioning Instruments
| Instrument | Domain | Notes |
|---|---|---|
| Wechsler Adult Intelligence Scale (WAIS-IV/V) | Intellectual functioning | Widely used; floor effects in severe ID |
| Stanford-Binet Intelligence Scales (5th ed.) | Intellectual functioning | Extended norms useful at lower ranges |
| Leiter International Performance Scale-3 | Non-verbal IQ | Useful for non-verbal or minimally verbal individuals |
| Vineland Adaptive Behavior Scales (VABS-3) | Adaptive functioning: communication, daily living, socialisation, motor | Informant-based; lifespan norms |
| Adaptive Behavior Assessment System (ABAS-3) | Adaptive functioning across conceptual, social, practical domains | Teacher/parent/clinician rated |
Psychiatric Assessment Instruments Adapted for ID
| Instrument | Purpose | Notes |
|---|---|---|
| Psychiatric Assessment Schedule for Adults with Developmental Disability (PAS-ADD) | Psychiatric diagnosis (ICD-based) | Clinician interview; requires informant; validated mild-moderate ID |
| Mini PAS-ADD | Psychiatric screening | Informant-rated; practical for community settings |
| Reiss Screen for Maladaptive Behavior | Broad psychopathology screening | Informant-rated |
| Glasgow Anxiety Scale for Intellectual Disability (GAS-ID) | Anxiety | Self-report; adapted language |
| Mood, Interest and Pleasure Questionnaire (MIPQ) | Depression | Suitable for severe ID; carer-completed |
| Developmental Behaviour Checklist (DBC) | Emotional and behavioural problems | Widely used in Australia; child and adult versions |
| Aberrant Behavior Checklist (ABC) | Irritability, lethargy, stereotypy, hyperactivity, inappropriate speech | Useful for treatment monitoring |
Caveat: Standard psychiatric rating scales (e.g. Hamilton Depression Rating Scale, PANSS) are not validated for moderate-profound ID and require replacement with ID-specific tools.
Physical Health Assessment
A medical cause for any behavioural or psychiatric change must be systematically excluded:
- Epilepsy review (seizure diary, AED levels, EEG as indicated)
- Thyroid function (especially Down syndrome)
- Vision and hearing assessment (particularly relevant in Aboriginal and Torres Strait Islander people with ID, who have markedly higher rates of sensory impairment than the general population)
- Pain assessment using observational tools (e.g. Non-Communicating Children's Pain Checklist)
- Dental health, GORD, constipation (common undetected pain sources in non-verbal individuals)
- Full medication review (polypharmacy and anticholinergic burden common)
- In Indigenous Australians: exclude syphilis, vitamin B12 deficiency, thyroid disease, and other reversible causes before attributing cognitive decline to dementia or ID
Culturally Appropriate Assessment in Aboriginal and Torres Strait Islander People
- Cultural concepts of disability and cognitive impairment differ; many Aboriginal families view cognitive difference within the context of broader community challenges rather than as a discrete disability
- Western cognitive tests are not validated for Aboriginal populations without adaptation; the Kimberley Indigenous Cognitive Assessment (KICA) is a validated tool for dementia screening in older Aboriginal Australians
- Clinicians must distinguish ID from: (a) acquired brain injury, (b) dementia (early onset, high prevalence in Indigenous Australians), (c) effects of social deprivation, trauma, or substance misuse, and (d) culturally specific communication styles
- High rates of dementia have been documented in Aboriginal Australians, with cognitive impairment and dementia often presenting at younger ages
- An interdisciplinary approach including culturally safe practitioners and community liaison is essential
Differential Diagnosis
| Condition | Key Distinguishing Features |
|---|---|
| Comorbid psychiatric disorder (e.g. MDD, schizophrenia) | Change from baseline; identifiable symptom cluster; responds to targeted treatment |
| ASD features (without comorbid psychiatric disorder) | Stable, pervasive pattern; not a departure from developmental baseline |
| Behavioural phenotype of underlying syndrome | Characteristic pattern without episodic change; part of enduring neurobehavioural profile |
| Dementia superimposed on ID (especially Down syndrome) | Progressive cognitive and functional decline; memory impairment; personality change; often early-onset |
| Pain or undetected medical illness | Acute behavioural change; temporal relationship to physical event; responds to analgesia/treatment |
| Adverse medication effects | Temporal relationship to medication change; improvement with dose reduction/cessation |
| PTSD | History of trauma (often abuse); re-experiencing, hyperarousal, avoidance |
| Delirium | Acute confusional state; altered consciousness; fluctuating course; identifiable medical cause |
| Acquired brain injury or dementia (mimicking ID) | Especially relevant in Aboriginal populations and older adults; requires longitudinal cognitive data |
Management
Multidisciplinary Team Roles
| Clinician | Key Roles |
|---|---|
| Psychiatrist | Assessment and management of mental illness, epilepsy, developmental disorders (ASD, ADHD) |
| Psychologist | Behavioural intervention, specialist therapies (CBT, PBS, anger/anxiety management, social skills) |
| Speech and Language Therapist | Communication assessment; dysphagia; AAC systems |
| Occupational Therapist | Activities, aids and adaptations; sensory integration (autism) |
| Physiotherapist | Mobility, contractures, seating |
| Dietitian | Special diets (dysphagia, autism, obesity) |
| Social Worker | Day activities, respite, residential care, benefits access |
| GP/Paediatrician | Primary physical health; early detection and referral |
Pharmacological Management
Pharmacological treatment should target identified psychiatric diagnoses, with dose adjustments for altered pharmacokinetics and increased side-effect sensitivity in ID.
| Indication | Agents | Considerations in ID |
|---|---|---|
| Major depressive disorder | SSRIs (sertraline, fluoxetine, escitalopram) | Start low, titrate slowly; monitor behavioural activation especially with ASD comorbidity |
| Bipolar disorder | Valproate, lithium, quetiapine, lamotrigine | Lithium requires careful monitoring; valproate useful when epilepsy also present; avoid valproate in women of childbearing potential |
| Psychotic disorder | Risperidone, olanzapine, aripiprazole, quetiapine | Increased sensitivity to EPS and metabolic effects; lowest effective dose; regular metabolic monitoring |
| Anxiety disorders | SSRIs, SNRIs; buspirone (adjunctive) | Behavioural interventions preferred first-line where possible |
| ADHD | Methylphenidate, dexamfetamine, atomoxetine | Evidence supports use in mild-moderate ID; monitor for tics and appetite suppression |
| Challenging behaviour (without primary psychiatric diagnosis) | Antipsychotics used cautiously | NICE NG54: advises against prescribing antipsychotics for challenging behaviour without comorbid mental disorder; regular review and active deprescribing plan required |
| Self-injurious behaviour | Naltrexone (limited evidence); behavioural approaches primary | Exclude pain, frustration, communication need first |
Key principle, polypharmacy: Antipsychotics are frequently prescribed for challenging behaviour in ID but evidence is limited and risks are significant. NICE NG54 (2016, reviewed 2020) recommends against this practice without a clear psychiatric indication, and mandates regular structured medication review with a view to rationalisation. Polypharmacy is prevalent and harmful.
Psychological Interventions
| Intervention | Evidence Base / Notes |
|---|---|
| Adapted CBT | Simplified language, visual aids, shorter sessions, concrete focus; evidence for depression, anxiety, anger |
| Positive Behaviour Support (PBS) | Evidence-based framework for challenging behaviour; environmental modification, communication support, skill building, quality-of-life focus |
| Functional Behaviour Assessment | Identifies antecedents, behaviours, consequences underpinning challenging behaviour |
| Adapted DBT | For emotional dysregulation and self-harm in mild ID |
| Grief and bereavement counselling | Often overlooked trigger for psychiatric decompensation; requires adaptation to cognitive level |
| Trauma-focused therapy (incl. adapted EMDR) | Trauma prevalent; safety must be established first |
| Social skills training | Beneficial for social anxiety, peer relations, vulnerability to exploitation |
Social and Community Interventions
- Communication support: Speech pathology and AAC systems reduce frustration and improve psychiatric assessment accuracy
- Stable, predictable environments: Minimise behavioural disturbance; supported accommodation
- Carer and family support: Psychoeducation, respite, support groups; carer stress is a major outcome determinant
- Community integration: Rights-based, least-restrictive, community-based care consistent with CRPD obligations
- NDIS (Australia): Funds reasonable and necessary supports; psychiatric comorbidity affects support planning and plan management
Prognosis
Prognosis for comorbid psychiatric disorders in ID is influenced by:
- Timely and accurate diagnosis (diagnostic overshadowing is the primary barrier)
- Severity of ID (more severe ID → greater communication difficulties, diagnostic challenge, poorer response to some modalities)
- Stability and quality of living environment and carer support
- Presence of epilepsy (associated with worse psychiatric outcomes)
- Availability of adapted psychological and behavioural interventions
- Early treatment of identified disorders
With appropriate treatment, many people with mild-moderate ID and comorbid mental illness achieve significant symptomatic improvement and functional gains. Severe and profound ID with psychiatric comorbidity requires ongoing specialist support.
Special Populations
Older Adults with ID
- Down syndrome: Alzheimer-type dementia onset often in the 40s-50s due to amyloid precursor protein gene dosage on chromosome 21; early-adulthood baseline cognitive assessment (ideally by age 30) is essential
- Depression may be the first presentation of dementia; distinguish carefully
- Exclude reversible causes: hypothyroidism, vitamin B12 deficiency, sensory impairment, medication toxicity, sleep apnoea
- Median survival for Aboriginal people with ID is markedly reduced (55.1 years for men, 64.0 years for women); leading causes of death include respiratory and circulatory disease and accidents
Children and Adolescents with ID
- Behavioural and emotional problems often present in the preschool period
- Stereotypic movement disorder: in the context of ID, DSM-5 no longer requires the behaviour to be severe enough to warrant independent clinical focus; stereotypic movements occur in approximately two-thirds of people with ID in residential settings; abrupt new onset may signal acute medical illness
- ADHD and ASD are commonly comorbid
- Developmental tools (Vineland Adaptive Behavior Scales, Griffiths Developmental Scales) central
- Australian Disability Standards for Education underpin educational support obligations
Pregnancy
- Women with ID: elevated risk of unplanned pregnancy, reduced antenatal access, child protection involvement
- Psychotropic medication risks in pregnancy apply equally; adapted shared decision-making required
- Valproate must be avoided in women of childbearing potential wherever possible (teratogenicity; neurodevelopmental risk to offspring)
- Capacity assessment for contraception and pregnancy-related decisions: use supported decision-making frameworks consistent with the CRPD
Medicolegal and Ethical Considerations
| Domain | Key Points |
|---|---|
| Capacity and consent | Presumption of capacity; capacity is decision-specific and may fluctuate; supported decision-making precedes substituted decision-making (CRPD) |
| Guardianship | State/territory legislation applies (e.g. Guardianship Act 1987 NSW; Guardianship and Administration Act 2000 Qld); jurisdiction-specific |
| Restrictive practices | Chemical, mechanical, and environmental restraint subject to legislative oversight; NDIS Quality and Safeguards Commission oversight required; behaviour support plan mandatory |
| Abuse and neglect | Significantly elevated risk in ID; mandatory reporting obligations apply; institutional abuse a recognised risk |
| Criminal justice | ID over-represented in custodial settings; unfit to stand trial provisions and forensic disability pathways exist across Australian jurisdictions; diagnostic overshadowing in custodial settings leaves psychiatric illness untreated; estimated 40-70% of inmates with ID have a diagnosable psychiatric disorder |
| NDIS | Funds reasonable and necessary supports for permanent significant disability; psychiatric comorbidity affects planning |
| RANZCP position | Affirms the right of people with ID to access quality mental health services equivalent to those available to the general population, with appropriately adapted assessment and treatment |
Sources